Geneva, Switzerland

Bernard Francois Mach




Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 200(Granted Patents)


Location History:

  • Geneva, CH (1996 - 2004)
  • Chambesy-Geneve, CH (2004)
  • Chambésy, CH (2010)
  • Chambesy, CH (2013 - 2020)

Company Filing History:


Years Active: 1996-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Bernard Francois Mach: A Pioneer in Antibody Innovation**

Introduction

Bernard Francois Mach, based in Geneva, Switzerland, is a remarkable inventor with a significant contribution to the field of immunology. With a portfolio of nine patents, his work primarily focuses on the development of fully human monoclonal antibodies, specifically targeting the CD3 antigen. His innovative approaches have opened new avenues in therapeutic applications.

Latest Patents

One of Bernard's latest patents is titled "Anti-CD3 antibodies and methods of use thereof." This invention revolves around antibodies that are directed to the antigen CD3, providing essential advancements in biomedical research. The patent outlines fully human monoclonal antibodies aimed at CD3, detailing nucleotide sequences encoding heavy and light chain immunoglobulin molecules. It includes sequences that span framework regions and complementarity determining regions (CDRs), which are crucial for the antibody's function. Additionally, the patent describes hybridomas and other cell lines that express these immunoglobulin molecules and monoclonal antibodies, further illustrating the breadth of his innovative work.

Career Highlights

Bernard has held significant positions in renowned companies throughout his career. Notably, he has contributed his expertise at Novimmune SA and bioMérieux, Inc. His work in these organizations has bolstered his reputation as a leading inventor in the field of antibody development.

Collaborations

Throughout his professional journey, Bernard has collaborated with notable coworkers such as Yann Dean and Marie Kosco-Vilbois. These collaborations have enriched his research and enhanced the development of therapeutic solutions in immunology.

Conclusion

In conclusion, Bernard Francois Mach's innovative spirit and dedication to advancing antibody technology have greatly impacted the field of biomedical research. His extensive patent portfolio and collaborations reflect a commitment to improving health outcomes through the development of targeted immunotherapies. As the landscape of immunology continues to evolve, inventors like Bernard play a crucial role in navigating the challenges and breakthroughs that lie ahead.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…